期刊文献+

上海市某社区宫颈癌疫苗宣教效果分析——以上海市某社区卫生服务中心为例

下载PDF
导出
摘要 我国宫颈癌发病率随着社会发展有不断上升和年轻化的趋势,做好宫颈癌防治已不但是医学问题,还是一个社会问题。国际上普遍采用疫苗接种作为预防宫颈癌的有效手段,上海也于2017年11月正式引进二价、四价宫颈癌疫苗。但居民对宫颈癌及疫苗的相关知识多数来源于网络,专业性无法确保,且没有系统性的了解,可能对疫苗本身和其接种产生误区。本文以上海市某社区宫颈癌疫苗宣教作为干预手段,对宣教前后的宫颈癌疫苗及接种等相关知识认知度做全面调查,并对宣教效果进行分析,发现专业的系统宣教非常必要,有利于推动'健康信念认同→态度向有利于健康转变→采纳健康行为'的逐步过渡,以期对宣教对象的接种意愿产生正向影响。
出处 《饮食科学》 2019年第6期233-233,共1页 Diet Science
  • 相关文献

二级参考文献26

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J]. CA Cancer J Clin,2011,61 (2) :69-90.
  • 2郝捷,赵平,陈万年,等.2013中国肿瘤登记年报[M].军事医学科学出版社,2014:68-72.
  • 3Rodriguez AC, Schiffman M, Herrero R, et al. Longitudinal study of human papillomavirus persistence and cervical in- traepithelial neoplasia grade 2/3:critical role of duration of infection[J]. J Natl Cancer Inst,2010,102 (5) :315- 324.
  • 4Kjaer SK, Frederiksen K, Munk C, et al. Long-term abso- lute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence[ J]. J Nail Cancer Inst,2010,102 (19) : 1478- 1488.
  • 5Kreimer AR, Schiffman M, Herrero R, et al. Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment [ J ]. Int J Cancer ,2012,131 ( 1 ) :211-218.
  • 6Koshiol J, Lindsay L, Pimenta JM, et al. Persistent human papillomavirus infection and cervical neoplasia:a system- atic review and meta-analysis [ J ]. Am J Epidemiol,2008, 168(2) :123-137.
  • 7Chen HC, Schiffman M, Lin CY, et al. Persistence of type- specific human papillomavirus infection and increased long-term risk of cervical cancer [ J ]. J Nat1 Cancer Inst, 2011,103(18) :1387-1396.
  • 8Castellsague X, Munoz N, Pitisuttithum P, et al. End-of- study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6,11,16,18) recombinant vaccine in adult women 24-45 years of age [ J ]. Br J Cancer, 2011,105 ( 1 ) :28-37.
  • 9Romanowski B, de Borba PC, Naud PS, et al. Sustained ef- ficacy and immunogenicity of the human papillomavirus ( HPV ) -16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years [ J ]. Lancet ,2009,374 ( 9706 ) : 1975-1985.
  • 10Szarewski. A, Poppe WA, Skinner SR, et al. Efficacy of the human papillomavirus (HPV) -16/18 ASIM-adjuvan- ted vaccine in women aged 15-25 years with and without serological evidence of pre'dous exposure to HPV-16/18[J]. Int J Cancer,2012,131 (1) :106-116.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部